相似文献
1
Statin use is not associated with reduced risk of skin cancer: a meta-analysis.
Br J Cancer. 2014 Feb 4;110(3):802-7. doi: 10.1038/bjc.2013.762. Epub 2013 Dec 24.
2
Statin use and risk of Parkinson's disease: A meta-analysis.
Behav Brain Res. 2016 Aug 1;309:29-34. doi: 10.1016/j.bbr.2016.04.046. Epub 2016 Apr 27.
3
Statin use and risk of pancreatic cancer: a meta-analysis.
Cancer Causes Control. 2012 Jul;23(7):1099-111. doi: 10.1007/s10552-012-9979-9. Epub 2012 May 5.
4
Statin use and risk of Parkinson's disease: a meta-analysis of observational studies.
J Neurol. 2013 Jan;260(1):158-65. doi: 10.1007/s00415-012-6606-3. Epub 2012 Jul 21.
5
Exploring association between statin use and breast cancer risk: an updated meta-analysis.
Arch Gynecol Obstet. 2017 Dec;296(6):1043-1053. doi: 10.1007/s00404-017-4533-3. Epub 2017 Sep 22.
6
Prospective analysis of association between use of statins and melanoma risk in the Women's Health Initiative.
Cancer. 2012 Oct 15;118(20):5124-31. doi: 10.1002/cncr.27497. Epub 2012 Mar 20.
7
Statin use and the risk of multiple myeloma: a PRISMA-compliant meta-analysis.
Ann Hematol. 2020 Aug;99(8):1805-1812. doi: 10.1007/s00277-020-04157-5. Epub 2020 Jun 29.
8
Systematic review and meta-analysis of studies assessing the relationship between statin use and risk of ovarian cancer.
Cancer Causes Control. 2020 Oct;31(10):869-879. doi: 10.1007/s10552-020-01327-8. Epub 2020 Jul 20.
9
The association between statin use and risk of age-related macular degeneration.
Sci Rep. 2015 Dec 14;5:18280. doi: 10.1038/srep18280.
10
Statin use and risk of prostate cancer: a meta-analysis of observational studies.
PLoS One. 2012;7(10):e46691. doi: 10.1371/journal.pone.0046691. Epub 2012 Oct 1.
引用本文的文献
1
Evaluation of the Association Between Statin Exposure and Skin Cancer: A Nationwide Case-Control Study in South Korea.
Indian J Dermatol. 2025 Sep-Oct;70(5):240-245. doi: 10.4103/ijd.ijd_1134_23. Epub 2025 Sep 1.
2
Risk Factors and Prevention of Cancer and CVDs: A Chicken and Egg Situation.
J Clin Med. 2025 Apr 29;14(9):3083. doi: 10.3390/jcm14093083.
3
Investigating potential anti-proliferative activity of different statins against five cancer cell lines.
Saudi Pharm J. 2023 May;31(5):727-735. doi: 10.1016/j.jsps.2023.03.013. Epub 2023 Mar 24.
4
Assessing the role of lipid-lowering therapy on multi-cancer prevention: A mendelian randomization study.
Front Pharmacol. 2023 Apr 19;14:1109580. doi: 10.3389/fphar.2023.1109580. eCollection 2023.
5
Cardiovascular Immunotoxicity Associated with Immune Checkpoint Inhibitors in Metastatic Melanoma.
Cancers (Basel). 2023 Apr 6;15(7):2170. doi: 10.3390/cancers15072170.
6
Photosensitizing Medications and Skin Cancer: A Comprehensive Review.
Cancers (Basel). 2021 May 12;13(10):2344. doi: 10.3390/cancers13102344.
7
Targeting SREBP-2-Regulated Mevalonate Metabolism for Cancer Therapy.
Front Oncol. 2020 Aug 21;10:1510. doi: 10.3389/fonc.2020.01510. eCollection 2020.
8
Statin use and prognosis of lung cancer: a systematic review and meta-analysis of observational studies and randomized controlled trials.
Drug Des Devel Ther. 2019 Jan 23;13:405-422. doi: 10.2147/DDDT.S187690. eCollection 2019.
9
Statin-induced metabolic reprogramming in head and neck cancer: a biomarker for targeting monocarboxylate transporters.
Sci Rep. 2018 Nov 14;8(1):16804. doi: 10.1038/s41598-018-35103-1.
10
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials.
Cancer. 2019 Jan 1;125(1):18-44. doi: 10.1002/cncr.31719. Epub 2018 Oct 3.
本文引用的文献
1
Immunotherapy for advanced melanoma: fulfilling the promise.
Cancer Treat Rev. 2013 Dec;39(8):879-85. doi: 10.1016/j.ctrv.2013.04.006. Epub 2013 May 29.
2
Common cancer risk and statins: a population-based case-control study in a Chinese population.
Expert Opin Drug Saf. 2013 Jan;12(1):19-27. doi: 10.1517/14740338.2013.744392. Epub 2012 Dec 1.
3
Statins and the risk of cancer after heart transplantation.
Circulation. 2012 Jul 24;126(4):440-7. doi: 10.1161/CIRCULATIONAHA.111.081059. Epub 2012 Jul 3.
4
Increased incidence of Merkel cell carcinoma among younger statin users.
Cancer Epidemiol. 2012 Oct;36(5):421-4. doi: 10.1016/j.canep.2012.05.006. Epub 2012 Jun 7.
5
Statins in dermatology: is nonmelanoma skin cancer the dark side of the moon?
Int J Dermatol. 2013 Jul;52(7):899-900. doi: 10.1111/j.1365-4632.2011.05067.x. Epub 2012 Apr 18.
6
Prospective analysis of association between use of statins and melanoma risk in the Women's Health Initiative.
Cancer. 2012 Oct 15;118(20):5124-31. doi: 10.1002/cncr.27497. Epub 2012 Mar 20.
7
Targeting tumor cell metabolism with statins.
Oncogene. 2012 Nov 29;31(48):4967-78. doi: 10.1038/onc.2012.6. Epub 2012 Feb 6.
8
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
BMJ. 2011 Oct 18;343:d5928. doi: 10.1136/bmj.d5928.
9
Fluvastatin enhances sorafenib cytotoxicity in melanoma cells via modulation of AKT and JNK signaling pathways.
Anticancer Res. 2011 Oct;31(10):3259-65.
10
Exposure to statins and risk of common cancers: a series of nested case-control studies.
BMC Cancer. 2011 Sep 26;11:409. doi: 10.1186/1471-2407-11-409.
Zotero 插件